Assessment of Retinal Nerve Fibre Layer by Optical Coherence Tomography in Uveitis Patients With Papilloedema

Assessment of optic disc morphology can be difficult in patients with uveitis and papilloedema. Therefore different optical coherence tomography (OCT) and laser scanning techniques may help to detect damage to the retinal nerve fibre layer.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Uveitis Cranial Nerve Diseases Eye Diseases Glaucoma Nervous System Diseases Ocular Hypertension Optic Nerve Diseases Papilledema Uveal Diseases Uveitis, Intermediate

Age range

18 year–100 year

Sex eligibility

All sexes

Study type

Observational

Primary location

Department of Ophthalmology at St.-Franziskus Hospital

Münster, 48145, Germany

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

anterior or intermediate uveitis
papilloedema
glaucoma

Exclusion criteria

dense cataract
dense vitreous opacification
circular posterior synechiae

Treatment and study plan

Primary outcomes

Alterations of retinal nerve fibre layer by optical coherence tomography

Time frame: once at study entry

Baseline comparision of retinal nerve fibre layer thickness in patients with uveitis and with or without papilloedema at study entry. No follow-up examination scheduled

Sponsors and collaborators

Lead sponsor

St. Franziskus Hospital

Other

Registry information

Official study title

Retinal Nerve Fibre Layer in Uveitic Secondary Glaucoma

Important dates

Study start: 2009
Primary completion: 2010
Study completion: 2011
First posted: Jul 27, 2010
Registry last updated: Nov 18, 2015

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.

Completed